Minerva Biotechnology and Biomolecular Research

Aims & Scope

Minerva Biotechnology and Biomolecular Research, a quarterly international, peer-reviewed scientific journal of Biotechnology and Molecular Biology, indexed in EMBASE, Science Citation Index Expanded (SCIE), Scopus has an impact factor of 2.024.

The journal publishes four issues of high-quality preclinical research articles (original articles, reviews, letters and editorials) per annum.

Our aim is to continue to improve the positive trends of recent years and publish scientific articles of great interest to basic researchers and clinical investigators.

The Journal offers a fast and rigorous peer review process as well as open access options.

Minerva Biotechnology and Biomolecular Research welcomes articles on a wide variety of molecular biotechnology applications with special focus on: Regenerative Medicine, Cancer, Host-Pathogen interactions and Microbiota, Biomarkers and biosensors, Drug Discovery, Immunology, Endocrinology, Metabolism, Bioinformatics.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	0.5
2024	0.70

SJR (SCImago Journal Rank)

Year	Value
2024	0.150

Quartile

Year	Value
2024	Q4

h-index

Year	Value
2024	22

Journal Rank

Year	Value
2024	24572

Journal Citation Indicator

Year	Value
2024	37

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Biochemistry, Genetics and Molecular Biology, Chemical Engineering and Immunology and Microbiology, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Hot topics in chronic inflammation-induced diseases at the time of COVID-19

  Citation: 13

  Authors: Tetyana, Rinaldo

• Vitamin D in the prevention and treatment of type-2 diabetes and associated diseases: a critical view during COVID-19 time

  Citation: 13

  Authors: Tetyana, Iuliia, Andrii, Oleksandr, Yuliia, Olena, Sharmila, Nazarii

• Immunomodulatory role of Faecalibacterium prausnitzii in obesity and metabolic disorders

  Citation: 11

  Authors: Yousefi, Mohammadlou, Bahar, Tetyana, Nazarii, Eslami

• Microbial and immune markers of patients with metabolic syndrome and cardiovascular diseases: perspectives for early diagnostics

  Citation: 10

  Authors: Tamara, Viktor, Tetyana, Nazarii, Nadiya

• A contemporary insight into SARS-CoV-2 pathophysiology, retrieved threat of mutants and prospect of vaccine development

  Citation: 10

  Authors: Rasmita, Sujata

• Systematic structure guided clustering of chemical lead compounds targeting RdRp of SARS-CoV-2

  Citation: 10

  Authors: Ahmad, Tulika, Essam M., Atiah H., Brij N., Mohd, Mustfa F., Pallavi, Shafiul

• The role of nanotechnology in food safety

  Citation: 5

  Authors: Carmela, Vincenzo, Luigi, Nazarii, Maria C., Immacolata, Ludovico

• Prediction of B- and T-cell epitopes using in-silico approaches: a solution to the development of recombinant vaccines against COVID-19

  Citation: 5

  Authors: Hassan, Vajihe, Pejman

• Neuroprotective effect of curcumin and curcumin-integrated nanocarriers in stroke: from mechanisms to therapeutic opportunities

  Citation: 5

  Authors: Javad, Zainab M., Charles O., Olugbenga, Deepak, Radha, Niharika, Manoj, Daniela

• Bioactive compounds from Prosopis species as potential oxidative stress and inflammation modulators: an update on mechanisms

  Citation: 5

  Authors: Javad, Naoual, Alibek, Naoufal, Nasreddine, Afaf A., Farukh, Abdelhakim, Jelena, Charles O., Olugbemi T., Miquel, Eda, Christophe, Daniela

---